¼Ò¾Æ ¸¸¼º BÇü °£¿° ȯ¾Æ¿¡¼ Interferon- ¥áÀÇ ¿ë·® Â÷ÀÌ ¹× ÀçÄ¡·á¿¡ µû¸¥ Ä¡·á È¿°ú ºñ±³
The Comparison of Interferon-¥á Treatment by Dosages and Retreatment for Chronic Hepatitis B in Children
Àåâȯ, ÀÌ°æÈñ, ȲÀ§°æ, ¿À±â¿ø, ¹Ú¿ì»ý, ÀÌÁØÈ, °íö¿ì, ÃÖº´È£,
¼Ò¼Ó »ó¼¼Á¤º¸
Àåâȯ ( Jang Chang-Hwan )
°æºÏ´ëÇб³ ÀÇ°ú´ëÇÐ ¼Ò¾Æ°úÇб³½Ç
ÀÌ°æÈñ ( Lee Kyung-Hee )
°æºÏ´ëÇб³ ÀÇ°ú´ëÇÐ ¼Ò¾Æ°úÇб³½Ç
ȲÀ§°æ ( Hwang Wi-Kyung )
°æºÏ´ëÇб³ ÀÇ°ú´ëÇÐ ¼Ò¾Æ°úÇб³½Ç
¿À±â¿ø ( Oh Ki-Won )
°æºÏ´ëÇб³ ÀÇ°ú´ëÇÐ ¼Ò¾Æ°úÇб³½Ç
¹Ú¿ì»ý ( Park Woo-Saeng )
°æºÏ´ëÇб³ ÀÇ°ú´ëÇÐ ¼Ò¾Æ°úÇб³½Ç
ÀÌÁØÈ ( Lee Jun-Hwa )
°æºÏ´ëÇб³ ÀÇ°ú´ëÇÐ ¼Ò¾Æ°úÇб³½Ç
°íö¿ì ( Ko Cheol-Woo )
°æºÏ´ëÇб³ ÀÇ°ú´ëÇÐ ¼Ò¾Æ°úÇб³½Ç
ÃÖº´È£ ( Choe Byung-Ho )
°æºÏ´ëÇб³ ÀÇ°ú´ëÇÐ ¼Ò¾Æ°úÇб³½Ç
KMID : 0816120030060020152
Abstract
Purpose: We compared the therapeutic efficacy of low dose with that of standard dose of interferon (IFN) treatment and also compared the first IFN treatment with retreattent.
Methods: We have studied 51 children (age, 2 ~14) treated for chronic hepatitis B from March 1990 to August 1999. Twenty seven children had been treated with 3 MU/m©÷ (2.66¡¾0.66 MU/m©÷) of IFN- ¥á three times a week for 6 months (range, 6 ~12 months), whereas 24 children with 6 MU/m©÷ (4.45¡¾0.94 MU/m©÷). There was no significant difference in gender, age, initial ALT and HBV DNA levels between each comparative group.
Results: Among the 27 children treated with 3 MU/m©÷ of IFN, ALT level had normalized in 11 children (41%) and anti-HBe seroconversion occurred in 9 children (33%) one year after the initiation of treatment. In comparison, among the 24 children treated with 6 MU/m2 of IFN, ALT normalized in 12 children (50%) and anti-HBe seroconversion occurred in 7 children (29%). In comparing the first treatment group to retreatment group, ALT level had normalized in 23 children (45%) and anti-HBe seroconversion occurred in 16 children (31%) among the 51 children treated with the first course of IFN treatment. In comparison, ALT normalized and anti-HBe seroconversion occurred in 3 children (25%) among the retreated 12 children.
Conclusion: There was no significant difference in the therapeutic efficacies between 3 MU/m©÷ and 6 MU/m©÷ dose of IFN treated groups in ALT normalization and anti-HBe seroconversion. The retreatment efficacy of IFN- a was as effective as the first treatment.
Å°¿öµå
Chronic hepatitis B;Interferon;Treatment;Children
¿ø¹® ¹× ¸µÅ©¾Æ¿ô Á¤º¸
µîÀçÀú³Î Á¤º¸